Positiv
●
Reuters
●
vor 5 Monaten
Zealand Pharma said on Friday its experimental obesity drug, co-developed with Swiss partner Roche , showed encouraging tolerability in a mid-stage trial, bolstering its push to take on market leaders with a potentially gentler alternative to existing blockbuster treatments.